Global NASH Drug Pipeline Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global NASH Drug Pipeline Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for NASH Drug Pipeline by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for NASH Drug Pipeline by Country/Region, 2017, 2022 & 2028

2.2 NASH Drug Pipeline Segment by Type

2.2.1 Protease Inhibitor

2.2.2 Immunomodulatory

2.2.3 Multiple Kinase Inhibitor

2.3 NASH Drug Pipeline Sales by Type

2.3.1 Global NASH Drug Pipeline Sales Market Share by Type (2017-2022)

2.3.2 Global NASH Drug Pipeline Revenue and Market Share by Type (2017-2022)

2.3.3 Global NASH Drug Pipeline Sale Price by Type (2017-2022)

2.4 NASH Drug Pipeline Segment by Application

2.4.1 Clinical

2.4.2 Academic Research

2.5 NASH Drug Pipeline Sales by Application

2.5.1 Global NASH Drug Pipeline Sale Market Share by Application (2017-2022)

2.5.2 Global NASH Drug Pipeline Revenue and Market Share by Application (2017-2022)

2.5.3 Global NASH Drug Pipeline Sale Price by Application (2017-2022)

3 Global NASH Drug Pipeline by Company

3.1 Global NASH Drug Pipeline Breakdown Data by Company

3.1.1 Global NASH Drug Pipeline Annual Sales by Company (2020-2022)

3.1.2 Global NASH Drug Pipeline Sales Market Share by Company (2020-2022)

3.2 Global NASH Drug Pipeline Annual Revenue by Company (2020-2022)

3.2.1 Global NASH Drug Pipeline Revenue by Company (2020-2022)

3.2.2 Global NASH Drug Pipeline Revenue Market Share by Company (2020-2022)

3.3 Global NASH Drug Pipeline Sale Price by Company

3.4 Key Manufacturers NASH Drug Pipeline Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers NASH Drug Pipeline Product Location Distribution

3.4.2 Players NASH Drug Pipeline Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for NASH Drug Pipeline by Geographic Region

4.1 World Historic NASH Drug Pipeline Market Size by Geographic Region (2017-2022)

4.1.1 Global NASH Drug Pipeline Annual Sales by Geographic Region (2017-2022)

4.1.2 Global NASH Drug Pipeline Annual Revenue by Geographic Region

4.2 World Historic NASH Drug Pipeline Market Size by Country/Region (2017-2022)

4.2.1 Global NASH Drug Pipeline Annual Sales by Country/Region (2017-2022)

4.2.2 Global NASH Drug Pipeline Annual Revenue by Country/Region

4.3 Americas NASH Drug Pipeline Sales Growth

4.4 APAC NASH Drug Pipeline Sales Growth

4.5 Europe NASH Drug Pipeline Sales Growth

4.6 Middle East & Africa NASH Drug Pipeline Sales Growth

5 Americas

5.1 Americas NASH Drug Pipeline Sales by Country

5.1.1 Americas NASH Drug Pipeline Sales by Country (2017-2022)

5.1.2 Americas NASH Drug Pipeline Revenue by Country (2017-2022)

5.2 Americas NASH Drug Pipeline Sales by Type

5.3 Americas NASH Drug Pipeline Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC NASH Drug Pipeline Sales by Region

6.1.1 APAC NASH Drug Pipeline Sales by Region (2017-2022)

6.1.2 APAC NASH Drug Pipeline Revenue by Region (2017-2022)

6.2 APAC NASH Drug Pipeline Sales by Type

6.3 APAC NASH Drug Pipeline Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe NASH Drug Pipeline by Country

7.1.1 Europe NASH Drug Pipeline Sales by Country (2017-2022)

7.1.2 Europe NASH Drug Pipeline Revenue by Country (2017-2022)

7.2 Europe NASH Drug Pipeline Sales by Type

7.3 Europe NASH Drug Pipeline Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa NASH Drug Pipeline by Country

8.1.1 Middle East & Africa NASH Drug Pipeline Sales by Country (2017-2022)

8.1.2 Middle East & Africa NASH Drug Pipeline Revenue by Country (2017-2022)

8.2 Middle East & Africa NASH Drug Pipeline Sales by Type

8.3 Middle East & Africa NASH Drug Pipeline Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of NASH Drug Pipeline

10.3 Manufacturing Process Analysis of NASH Drug Pipeline

10.4 Industry Chain Structure of NASH Drug Pipeline

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 NASH Drug Pipeline Distributors

11.3 NASH Drug Pipeline Customer

12 World Forecast Review for NASH Drug Pipeline by Geographic Region

12.1 Global NASH Drug Pipeline Market Size Forecast by Region

12.1.1 Global NASH Drug Pipeline Forecast by Region (2023-2028)

12.1.2 Global NASH Drug Pipeline Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global NASH Drug Pipeline Forecast by Type

12.7 Global NASH Drug Pipeline Forecast by Application

13 Key Players Analysis

13.1 Intercept

13.1.1 Intercept Company Information

13.1.2 Intercept NASH Drug Pipeline Product Offered

13.1.3 Intercept NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Intercept Main Business Overview

13.1.5 Intercept Latest Developments

13.2 Genfit

13.2.1 Genfit Company Information

13.2.2 Genfit NASH Drug Pipeline Product Offered

13.2.3 Genfit NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Genfit Main Business Overview

13.2.5 Genfit Latest Developments

13.3 Allergan

13.3.1 Allergan Company Information

13.3.2 Allergan NASH Drug Pipeline Product Offered

13.3.3 Allergan NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Allergan Main Business Overview

13.3.5 Allergan Latest Developments

13.4 Madrigal

13.4.1 Madrigal Company Information

13.4.2 Madrigal NASH Drug Pipeline Product Offered

13.4.3 Madrigal NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Madrigal Main Business Overview

13.4.5 Madrigal Latest Developments

13.5 Immuron

13.5.1 Immuron Company Information

13.5.2 Immuron NASH Drug Pipeline Product Offered

13.5.3 Immuron NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Immuron Main Business Overview

13.5.5 Immuron Latest Developments

13.6 Galectin

13.6.1 Galectin Company Information

13.6.2 Galectin NASH Drug Pipeline Product Offered

13.6.3 Galectin NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Galectin Main Business Overview

13.6.5 Galectin Latest Developments

13.7 Gilead

13.7.1 Gilead Company Information

13.7.2 Gilead NASH Drug Pipeline Product Offered

13.7.3 Gilead NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Gilead Main Business Overview

13.7.5 Gilead Latest Developments

13.8 89bio Inc

13.8.1 89bio Inc Company Information

13.8.2 89bio Inc NASH Drug Pipeline Product Offered

13.8.3 89bio Inc NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 89bio Inc Main Business Overview

13.8.5 89bio Inc Latest Developments

13.9 ABIONYX Pharma SA

13.9.1 ABIONYX Pharma SA Company Information

13.9.2 ABIONYX Pharma SA NASH Drug Pipeline Product Offered

13.9.3 ABIONYX Pharma SA NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ABIONYX Pharma SA Main Business Overview

13.9.5 ABIONYX Pharma SA Latest Developments

13.10 Abivax SA

13.10.1 Abivax SA Company Information

13.10.2 Abivax SA NASH Drug Pipeline Product Offered

13.10.3 Abivax SA NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Abivax SA Main Business Overview

13.10.5 Abivax SA Latest Developments

13.11 Abliva AB

13.11.1 Abliva AB Company Information

13.11.2 Abliva AB NASH Drug Pipeline Product Offered

13.11.3 Abliva AB NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Abliva AB Main Business Overview

13.11.5 Abliva AB Latest Developments

13.12 Acquist Therapeutics

13.12.1 Acquist Therapeutics Company Information

13.12.2 Acquist Therapeutics NASH Drug Pipeline Product Offered

13.12.3 Acquist Therapeutics NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Acquist Therapeutics Main Business Overview

13.12.5 Acquist Therapeutics Latest Developments

13.13 AdAlta Ltd

13.13.1 AdAlta Ltd Company Information

13.13.2 AdAlta Ltd NASH Drug Pipeline Product Offered

13.13.3 AdAlta Ltd NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 AdAlta Ltd Main Business Overview

13.13.5 AdAlta Ltd Latest Developments

13.14 Afimmune Biopharma Ltd

13.14.1 Afimmune Biopharma Ltd Company Information

13.14.2 Afimmune Biopharma Ltd NASH Drug Pipeline Product Offered

13.14.3 Afimmune Biopharma Ltd NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Afimmune Biopharma Ltd Main Business Overview

13.14.5 Afimmune Biopharma Ltd Latest Developments

13.15 Zhejiang Doer Biologics Corp

13.15.1 Zhejiang Doer Biologics Corp Company Information

13.15.2 Zhejiang Doer Biologics Corp NASH Drug Pipeline Product Offered

13.15.3 Zhejiang Doer Biologics Corp NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Zhejiang Doer Biologics Corp Main Business Overview

13.15.5 Zhejiang Doer Biologics Corp Latest Developments

13.16 Dicerna Pharmaceuticals Inc

13.16.1 Dicerna Pharmaceuticals Inc Company Information

13.16.2 Dicerna Pharmaceuticals Inc NASH Drug Pipeline Product Offered

13.16.3 Dicerna Pharmaceuticals Inc NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Dicerna Pharmaceuticals Inc Main Business Overview

13.16.5 Dicerna Pharmaceuticals Inc Latest Developments

13.17 ChemomAb Ltd

13.17.1 ChemomAb Ltd Company Information

13.17.2 ChemomAb Ltd NASH Drug Pipeline Product Offered

13.17.3 ChemomAb Ltd NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 ChemomAb Ltd Main Business Overview

13.17.5 ChemomAb Ltd Latest Developments

13.18 DURECT Corp

13.18.1 DURECT Corp Company Information

13.18.2 DURECT Corp NASH Drug Pipeline Product Offered

13.18.3 DURECT Corp NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 DURECT Corp Main Business Overview

13.18.5 DURECT Corp Latest Developments

13.19 Eli Lilly and Co

13.19.1 Eli Lilly and Co Company Information

13.19.2 Eli Lilly and Co NASH Drug Pipeline Product Offered

13.19.3 Eli Lilly and Co NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Eli Lilly and Co Main Business Overview

13.19.5 Eli Lilly and Co Latest Developments

13.20 Enanta Pharmaceuticals Inc

13.20.1 Enanta Pharmaceuticals Inc Company Information

13.20.2 Enanta Pharmaceuticals Inc NASH Drug Pipeline Product Offered

13.20.3 Enanta Pharmaceuticals Inc NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Enanta Pharmaceuticals Inc Main Business Overview

13.20.5 Enanta Pharmaceuticals Inc Latest Developments

13.21 EncuraGen Inc

13.21.1 EncuraGen Inc Company Information

13.21.2 EncuraGen Inc NASH Drug Pipeline Product Offered

13.21.3 EncuraGen Inc NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 EncuraGen Inc Main Business Overview

13.21.5 EncuraGen Inc Latest Developments

13.22 Engitix Ltd

13.22.1 Engitix Ltd Company Information

13.22.2 Engitix Ltd NASH Drug Pipeline Product Offered

13.22.3 Engitix Ltd NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Engitix Ltd Main Business Overview

13.22.5 Engitix Ltd Latest Developments

13.23 Heprotech Inc

13.23.1 Heprotech Inc Company Information

13.23.2 Heprotech Inc NASH Drug Pipeline Product Offered

13.23.3 Heprotech Inc NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Heprotech Inc Main Business Overview

13.23.5 Heprotech Inc Latest Developments

13.24 Hinova Pharmaceuticals Inc

13.24.1 Hinova Pharmaceuticals Inc Company Information

13.24.2 Hinova Pharmaceuticals Inc NASH Drug Pipeline Product Offered

13.24.3 Hinova Pharmaceuticals Inc NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Hinova Pharmaceuticals Inc Main Business Overview

13.24.5 Hinova Pharmaceuticals Inc Latest Developments

13.25 HK inno.N Corp

13.25.1 HK inno.N Corp Company Information

13.25.2 HK inno.N Corp NASH Drug Pipeline Product Offered

13.25.3 HK inno.N Corp NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 HK inno.N Corp Main Business Overview

13.25.5 HK inno.N Corp Latest Developments

13.26 HotSpot Therapeutics Inc

13.26.1 HotSpot Therapeutics Inc Company Information

13.26.2 HotSpot Therapeutics Inc NASH Drug Pipeline Product Offered

13.26.3 HotSpot Therapeutics Inc NASH Drug Pipeline Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 HotSpot Therapeutics Inc Main Business Overview

13.26.5 HotSpot Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

Table 1. NASH Drug Pipeline Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. NASH Drug Pipeline Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Protease Inhibitor

Table 4. Major Players of Immunomodulatory

Table 5. Major Players of Multiple Kinase Inhibitor

Table 6. Global NASH Drug Pipeline Sales by Type (2017-2022) & (K Units)

Table 7. Global NASH Drug Pipeline Sales Market Share by Type (2017-2022)

Table 8. Global NASH Drug Pipeline Revenue by Type (2017-2022) & ($ million)

Table 9. Global NASH Drug Pipeline Revenue Market Share by Type (2017-2022)

Table 10. Global NASH Drug Pipeline Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global NASH Drug Pipeline Sales by Application (2017-2022) & (K Units)

Table 12. Global NASH Drug Pipeline Sales Market Share by Application (2017-2022)

Table 13. Global NASH Drug Pipeline Revenue by Application (2017-2022)

Table 14. Global NASH Drug Pipeline Revenue Market Share by Application (2017-2022)

Table 15. Global NASH Drug Pipeline Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global NASH Drug Pipeline Sales by Company (2020-2022) & (K Units)

Table 17. Global NASH Drug Pipeline Sales Market Share by Company (2020-2022)

Table 18. Global NASH Drug Pipeline Revenue by Company (2020-2022) ($ Millions)

Table 19. Global NASH Drug Pipeline Revenue Market Share by Company (2020-2022)

Table 20. Global NASH Drug Pipeline Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers NASH Drug Pipeline Producing Area Distribution and Sales Area

Table 22. Players NASH Drug Pipeline Products Offered

Table 23. NASH Drug Pipeline Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global NASH Drug Pipeline Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global NASH Drug Pipeline Sales Market Share Geographic Region (2017-2022)

Table 28. Global NASH Drug Pipeline Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global NASH Drug Pipeline Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global NASH Drug Pipeline Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global NASH Drug Pipeline Sales Market Share by Country/Region (2017-2022)

Table 32. Global NASH Drug Pipeline Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global NASH Drug Pipeline Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas NASH Drug Pipeline Sales by Country (2017-2022) & (K Units)

Table 35. Americas NASH Drug Pipeline Sales Market Share by Country (2017-2022)

Table 36. Americas NASH Drug Pipeline Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas NASH Drug Pipeline Revenue Market Share by Country (2017-2022)

Table 38. Americas NASH Drug Pipeline Sales by Type (2017-2022) & (K Units)

Table 39. Americas NASH Drug Pipeline Sales Market Share by Type (2017-2022)

Table 40. Americas NASH Drug Pipeline Sales by Application (2017-2022) & (K Units)

Table 41. Americas NASH Drug Pipeline Sales Market Share by Application (2017-2022)

Table 42. APAC NASH Drug Pipeline Sales by Region (2017-2022) & (K Units)

Table 43. APAC NASH Drug Pipeline Sales Market Share by Region (2017-2022)

Table 44. APAC NASH Drug Pipeline Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC NASH Drug Pipeline Revenue Market Share by Region (2017-2022)

Table 46. APAC NASH Drug Pipeline Sales by Type (2017-2022) & (K Units)

Table 47. APAC NASH Drug Pipeline Sales Market Share by Type (2017-2022)

Table 48. APAC NASH Drug Pipeline Sales by Application (2017-2022) & (K Units)

Table 49. APAC NASH Drug Pipeline Sales Market Share by Application (2017-2022)

Table 50. Europe NASH Drug Pipeline Sales by Country (2017-2022) & (K Units)

Table 51. Europe NASH Drug Pipeline Sales Market Share by Country (2017-2022)

Table 52. Europe NASH Drug Pipeline Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe NASH Drug Pipeline Revenue Market Share by Country (2017-2022)

Table 54. Europe NASH Drug Pipeline Sales by Type (2017-2022) & (K Units)

Table 55. Europe NASH Drug Pipeline Sales Market Share by Type (2017-2022)

Table 56. Europe NASH Drug Pipeline Sales by Application (2017-2022) & (K Units)

Table 57. Europe NASH Drug Pipeline Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa NASH Drug Pipeline Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa NASH Drug Pipeline Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa NASH Drug Pipeline Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa NASH Drug Pipeline Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa NASH Drug Pipeline Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa NASH Drug Pipeline Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa NASH Drug Pipeline Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa NASH Drug Pipeline Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of NASH Drug Pipeline

Table 67. Key Market Challenges & Risks of NASH Drug Pipeline

Table 68. Key Industry Trends of NASH Drug Pipeline

Table 69. NASH Drug Pipeline Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. NASH Drug Pipeline Distributors List

Table 72. NASH Drug Pipeline Customer List

Table 73. Global NASH Drug Pipeline Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global NASH Drug Pipeline Sales Market Forecast by Region

Table 75. Global NASH Drug Pipeline Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global NASH Drug Pipeline Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas NASH Drug Pipeline Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas NASH Drug Pipeline Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC NASH Drug Pipeline Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC NASH Drug Pipeline Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe NASH Drug Pipeline Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe NASH Drug Pipeline Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa NASH Drug Pipeline Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa NASH Drug Pipeline Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global NASH Drug Pipeline Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global NASH Drug Pipeline Sales Market Share Forecast by Type (2023-2028)

Table 87. Global NASH Drug Pipeline Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global NASH Drug Pipeline Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global NASH Drug Pipeline Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global NASH Drug Pipeline Sales Market Share Forecast by Application (2023-2028)

Table 91. Global NASH Drug Pipeline Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global NASH Drug Pipeline Revenue Market Share Forecast by Application (2023-2028)

Table 93. Intercept Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 94. Intercept NASH Drug Pipeline Product Offered

Table 95. Intercept NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Intercept Main Business

Table 97. Intercept Latest Developments

Table 98. Genfit Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 99. Genfit NASH Drug Pipeline Product Offered

Table 100. Genfit NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Genfit Main Business

Table 102. Genfit Latest Developments

Table 103. Allergan Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 104. Allergan NASH Drug Pipeline Product Offered

Table 105. Allergan NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Allergan Main Business

Table 107. Allergan Latest Developments

Table 108. Madrigal Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 109. Madrigal NASH Drug Pipeline Product Offered

Table 110. Madrigal NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Madrigal Main Business

Table 112. Madrigal Latest Developments

Table 113. Immuron Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 114. Immuron NASH Drug Pipeline Product Offered

Table 115. Immuron NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Immuron Main Business

Table 117. Immuron Latest Developments

Table 118. Galectin Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 119. Galectin NASH Drug Pipeline Product Offered

Table 120. Galectin NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Galectin Main Business

Table 122. Galectin Latest Developments

Table 123. Gilead Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 124. Gilead NASH Drug Pipeline Product Offered

Table 125. Gilead NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Gilead Main Business

Table 127. Gilead Latest Developments

Table 128. 89bio Inc Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 129. 89bio Inc NASH Drug Pipeline Product Offered

Table 130. 89bio Inc NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. 89bio Inc Main Business

Table 132. 89bio Inc Latest Developments

Table 133. ABIONYX Pharma SA Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 134. ABIONYX Pharma SA NASH Drug Pipeline Product Offered

Table 135. ABIONYX Pharma SA NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. ABIONYX Pharma SA Main Business

Table 137. ABIONYX Pharma SA Latest Developments

Table 138. Abivax SA Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 139. Abivax SA NASH Drug Pipeline Product Offered

Table 140. Abivax SA NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Abivax SA Main Business

Table 142. Abivax SA Latest Developments

Table 143. Abliva AB Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 144. Abliva AB NASH Drug Pipeline Product Offered

Table 145. Abliva AB NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Abliva AB Main Business

Table 147. Abliva AB Latest Developments

Table 148. Acquist Therapeutics Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 149. Acquist Therapeutics NASH Drug Pipeline Product Offered

Table 150. Acquist Therapeutics NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Acquist Therapeutics Main Business

Table 152. Acquist Therapeutics Latest Developments

Table 153. AdAlta Ltd Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 154. AdAlta Ltd NASH Drug Pipeline Product Offered

Table 155. AdAlta Ltd NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. AdAlta Ltd Main Business

Table 157. AdAlta Ltd Latest Developments

Table 158. Afimmune Biopharma Ltd Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 159. Afimmune Biopharma Ltd NASH Drug Pipeline Product Offered

Table 160. Afimmune Biopharma Ltd NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Afimmune Biopharma Ltd Main Business

Table 162. Afimmune Biopharma Ltd Latest Developments

Table 163. Zhejiang Doer Biologics Corp Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 164. Zhejiang Doer Biologics Corp NASH Drug Pipeline Product Offered

Table 165. Zhejiang Doer Biologics Corp NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Zhejiang Doer Biologics Corp Main Business

Table 167. Zhejiang Doer Biologics Corp Latest Developments

Table 168. Dicerna Pharmaceuticals Inc Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 169. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Product Offered

Table 170. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Dicerna Pharmaceuticals Inc Main Business

Table 172. Dicerna Pharmaceuticals Inc Latest Developments

Table 173. ChemomAb Ltd Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 174. ChemomAb Ltd NASH Drug Pipeline Product Offered

Table 175. ChemomAb Ltd NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. ChemomAb Ltd Main Business

Table 177. ChemomAb Ltd Latest Developments

Table 178. DURECT Corp Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 179. DURECT Corp NASH Drug Pipeline Product Offered

Table 180. DURECT Corp NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 181. DURECT Corp Main Business

Table 182. DURECT Corp Latest Developments

Table 183. Eli Lilly and Co Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 184. Eli Lilly and Co NASH Drug Pipeline Product Offered

Table 185. Eli Lilly and Co NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 186. Eli Lilly and Co Main Business

Table 187. Eli Lilly and Co Latest Developments

Table 188. Enanta Pharmaceuticals Inc Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 189. Enanta Pharmaceuticals Inc NASH Drug Pipeline Product Offered

Table 190. Enanta Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 191. Enanta Pharmaceuticals Inc Main Business

Table 192. Enanta Pharmaceuticals Inc Latest Developments

Table 193. EncuraGen Inc Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 194. EncuraGen Inc NASH Drug Pipeline Product Offered

Table 195. EncuraGen Inc NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 196. EncuraGen Inc Main Business

Table 197. EncuraGen Inc Latest Developments

Table 198. Engitix Ltd Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 199. Engitix Ltd NASH Drug Pipeline Product Offered

Table 200. Engitix Ltd NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 201. Engitix Ltd Main Business

Table 202. Engitix Ltd Latest Developments

Table 203. Heprotech Inc Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 204. Heprotech Inc NASH Drug Pipeline Product Offered

Table 205. Heprotech Inc NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 206. Heprotech Inc Main Business

Table 207. Heprotech Inc Latest Developments

Table 208. Hinova Pharmaceuticals Inc Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 209. Hinova Pharmaceuticals Inc NASH Drug Pipeline Product Offered

Table 210. Hinova Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 211. Hinova Pharmaceuticals Inc Main Business

Table 212. Hinova Pharmaceuticals Inc Latest Developments

Table 213. HK inno.N Corp Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 214. HK inno.N Corp NASH Drug Pipeline Product Offered

Table 215. HK inno.N Corp NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 216. HK inno.N Corp Main Business

Table 217. HK inno.N Corp Latest Developments

Table 218. HotSpot Therapeutics Inc Basic Information, NASH Drug Pipeline Manufacturing Base, Sales Area and Its Competitors

Table 219. HotSpot Therapeutics Inc NASH Drug Pipeline Product Offered

Table 220. HotSpot Therapeutics Inc NASH Drug Pipeline Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 221. HotSpot Therapeutics Inc Main Business

Table 222. HotSpot Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of NASH Drug Pipeline

Figure 2. NASH Drug Pipeline Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global NASH Drug Pipeline Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global NASH Drug Pipeline Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. NASH Drug Pipeline Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Protease Inhibitor

Figure 10. Product Picture of Immunomodulatory

Figure 11. Product Picture of Multiple Kinase Inhibitor

Figure 12. Global NASH Drug Pipeline Sales Market Share by Type in 2021

Figure 13. Global NASH Drug Pipeline Revenue Market Share by Type (2017-2022)

Figure 14. NASH Drug Pipeline Consumed in Clinical

Figure 15. Global NASH Drug Pipeline Market: Clinical (2017-2022) & (K Units)

Figure 16. NASH Drug Pipeline Consumed in Academic Research

Figure 17. Global NASH Drug Pipeline Market: Academic Research (2017-2022) & (K Units)

Figure 18. Global NASH Drug Pipeline Sales Market Share by Application (2017-2022)

Figure 19. Global NASH Drug Pipeline Revenue Market Share by Application in 2021

Figure 20. NASH Drug Pipeline Revenue Market by Company in 2021 ($ Million)

Figure 21. Global NASH Drug Pipeline Revenue Market Share by Company in 2021

Figure 22. Global NASH Drug Pipeline Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global NASH Drug Pipeline Revenue Market Share by Geographic Region in 2021

Figure 24. Global NASH Drug Pipeline Sales Market Share by Region (2017-2022)

Figure 25. Global NASH Drug Pipeline Revenue Market Share by Country/Region in 2021

Figure 26. Americas NASH Drug Pipeline Sales 2017-2022 (K Units)

Figure 27. Americas NASH Drug Pipeline Revenue 2017-2022 ($ Millions)

Figure 28. APAC NASH Drug Pipeline Sales 2017-2022 (K Units)

Figure 29. APAC NASH Drug Pipeline Revenue 2017-2022 ($ Millions)

Figure 30. Europe NASH Drug Pipeline Sales 2017-2022 (K Units)

Figure 31. Europe NASH Drug Pipeline Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa NASH Drug Pipeline Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa NASH Drug Pipeline Revenue 2017-2022 ($ Millions)

Figure 34. Americas NASH Drug Pipeline Sales Market Share by Country in 2021

Figure 35. Americas NASH Drug Pipeline Revenue Market Share by Country in 2021

Figure 36. United States NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC NASH Drug Pipeline Sales Market Share by Region in 2021

Figure 41. APAC NASH Drug Pipeline Revenue Market Share by Regions in 2021

Figure 42. China NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 46. India NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe NASH Drug Pipeline Sales Market Share by Country in 2021

Figure 49. Europe NASH Drug Pipeline Revenue Market Share by Country in 2021

Figure 50. Germany NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 51. France NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa NASH Drug Pipeline Sales Market Share by Country in 2021

Figure 56. Middle East & Africa NASH Drug Pipeline Revenue Market Share by Country in 2021

Figure 57. Egypt NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country NASH Drug Pipeline Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of NASH Drug Pipeline in 2021

Figure 63. Manufacturing Process Analysis of NASH Drug Pipeline

Figure 64. Industry Chain Structure of NASH Drug Pipeline

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles